{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T10:35:04Z","timestamp":1791196504440,"version":"4.1.0"},"reference-count":100,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","surgonc.theclinics.com","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Surgical Oncology Clinics of North America"],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.1016\/j.soc.2014.09.001","type":"journal-article","created":{"date-parts":[[2014,10,4]],"date-time":"2014-10-04T11:19:08Z","timestamp":1412421548000},"page":"1-17","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":230,"title":["Epidemiology of Hepatocellular Carcinoma"],"prefix":"10.1016","volume":"24","author":[{"given":"Kelly J.","family":"Lafaro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aram N.","family":"Demirjian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy M.","family":"Pawlik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.soc.2014.09.001_bib1","series-title":"GLOBOCAN 2008 v2.0, Cancer incidence and mortality worldwide: IARC CancerBase No. 10","author":"Ferlay","year":"2010"},{"issue":"4","key":"10.1016\/j.soc.2014.09.001_bib2","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1586\/egh.09.35","article-title":"Hepatocellular carcinoma: current trends in worldwide epidemiology, risk factors, diagnosis and therapeutics","volume":"3","author":"Shariff","year":"2009","journal-title":"Expert Rev Gastroenterol Hepatol"},{"issue":"10","key":"10.1016\/j.soc.2014.09.001_bib3","doi-asserted-by":"crossref","first-page":"S158","DOI":"10.1097\/00004836-200411003-00008","article-title":"Global epidemiology of hepatitis B virus","volume":"38","author":"Custer","year":"2004","journal-title":"J\u00a0Clin Gastroenterol"},{"issue":"19","key":"10.1016\/j.soc.2014.09.001_bib4","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1093\/jnci\/djp288","article-title":"Decreased incidence of hepatocellular carcinoma in hepatitis B vaccinees: a 20-year follow-up study","volume":"101","author":"Chang","year":"2009","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"7","key":"10.1016\/j.soc.2014.09.001_bib5","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.1053\/j.gastro.2007.04.061","article-title":"Hepatocellular carcinoma: epidemiology and molecular carcinogenesis","volume":"132","author":"El-Serag","year":"2007","journal-title":"Gastroenterology"},{"issue":"S1","key":"10.1016\/j.soc.2014.09.001_bib6","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1159\/000048270","article-title":"Hepatocellular carcinoma associated with hepatitis C virus infection in Japan: projection to other countries in the foreseeable future","volume":"62","author":"Yoshizawa","year":"2002","journal-title":"Oncology"},{"issue":"5","key":"10.1016\/j.soc.2014.09.001_bib7","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1053\/j.gastro.2004.09.014","article-title":"Hepatocellular carcinoma in cirrhosis: incidence and risk factors","volume":"127","author":"Fattovich","year":"2004","journal-title":"Gastroenterology"},{"issue":"162","key":"10.1016\/j.soc.2014.09.001_bib8","first-page":"1","article-title":"HCV genotype 1a shows a better virologic response to antiviral therapy than HCV genotype 1b","volume":"12","author":"Pellicelli","year":"2012","journal-title":"BMC Gastroenterol"},{"issue":"2","key":"10.1016\/j.soc.2014.09.001_bib9","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S1665-2681(19)31354-7","article-title":"Epidemiology of hepatocellular carcinoma in sub-Saharan Africa","volume":"12","author":"Kew","year":"2013","journal-title":"Ann Hepatol"},{"issue":"9","key":"10.1016\/j.soc.2014.09.001_bib10","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1200\/JCO.2008.20.7753","article-title":"Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005","volume":"27","author":"Altekruse","year":"2009","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.soc.2014.09.001_bib11","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1097\/MCG.0b013e3182872f29","article-title":"Epidemiology of hepatocellular carcinoma: consider the population","volume":"47","author":"Mittal","year":"2013","journal-title":"J\u00a0Clin Gastroenterol"},{"issue":"2","key":"10.1016\/j.soc.2014.09.001_bib12","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.cld.2004.12.009","article-title":"Epidemiology of hepatocellular carcinoma","volume":"9","author":"Bosch","year":"2005","journal-title":"Clin Liver Dis"},{"issue":"5","key":"10.1016\/j.soc.2014.09.001_bib13","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1002\/hep.21196","article-title":"Signal transduction cascades and hepatitis B and C related hepatocellular carcinoma","volume":"43","author":"Branda","year":"2006","journal-title":"Hepatology"},{"issue":"16","key":"10.1016\/j.soc.2014.09.001_bib14","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1038\/onc.2010.36","article-title":"Viral hepatocarcinogenesis","volume":"29","author":"Tsai","year":"2010","journal-title":"Oncogene"},{"issue":"8256","key":"10.1016\/j.soc.2014.09.001_bib15","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/S0140-6736(81)90585-7","article-title":"Hepatocellular carcinoma and hepatitis B virus: a prospective study of 22,707 men in Taiwan","volume":"2","author":"Beasley","year":"1981","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.soc.2014.09.001_bib16","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S1590-8658(01)80062-1","article-title":"Hepatocellular carcinoma: global epidemiology","volume":"33","author":"Tabor","year":"2001","journal-title":"Dig Liver Dis"},{"issue":"2","key":"10.1016\/j.soc.2014.09.001_bib17","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1007\/s12072-008-9112-z","article-title":"The influence of hepatitis B virus genotype and subgenotype on the natural history of chronic hepatitis B","volume":"3","author":"McMahon","year":"2009","journal-title":"Hepatol Int"},{"issue":"10","key":"10.1016\/j.soc.2014.09.001_bib18","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1136\/gut.2003.033324","article-title":"Genotype C hepatitis B virus infection is associated with an increased risk of hepatocellular carcinoma","volume":"53","author":"Chan","year":"2004","journal-title":"Gut"},{"issue":"3","key":"10.1016\/j.soc.2014.09.001_bib19","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/S0016-5085(00)70261-7","article-title":"Hepatitis B genotypes correlate with clinical outcomes in patients with chronic hepatitis B","volume":"118","author":"Kao","year":"2000","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.soc.2014.09.001_bib20","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1080\/00365521.2018.12027892","article-title":"Prevalence and clinical implications of hepatitis B virus genotypes in southern Taiwan","volume":"38","author":"Lee","year":"2003","journal-title":"Scand J Gastroenterol"},{"issue":"15","key":"10.1016\/j.soc.2014.09.001_bib21","doi-asserted-by":"crossref","first-page":"2238","DOI":"10.3748\/wjg.v11.i15.2238","article-title":"Hepatitis B virus genotypes and hepatocellular carcinoma in Thailand","volume":"11","author":"Tangkijvanich","year":"2005","journal-title":"World J Gastroenterol"},{"issue":"4","key":"10.1016\/j.soc.2014.09.001_bib22","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/S0002-9440(10)64980-2","article-title":"Rous-Whipple award lecture. Viruses, immunity, and cancer: lessons from hepatitis B","volume":"156","author":"Chisari","year":"2000","journal-title":"Am J Pathol"},{"issue":"1","key":"10.1016\/j.soc.2014.09.001_bib23","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1053\/jhep.2002.30203","article-title":"Increase in de novo HBV DNA integrations in response to oxidative DNA damage or inhibition of poly(ADP-ribosyl)ation","volume":"35","author":"Dandri","year":"2002","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.soc.2014.09.001_bib24","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/j.jhep.2005.02.005","article-title":"The role of hepatitis B virus integrations in the pathogenesis of human hepatocellular carcinoma","volume":"42","author":"Bonilla Guerrero","year":"2005","journal-title":"J\u00a0Hepatol"},{"issue":"24","key":"10.1016\/j.soc.2014.09.001_bib25","doi-asserted-by":"crossref","first-page":"3813","DOI":"10.1038\/sj.onc.1206528","article-title":"Integrations of the hepatitis B virus (HBV) and human papillomavirus (HPV) into the human telomerase reverse transcriptase (hTERT) gene in liver and cervical cancers","volume":"22","author":"Ferber","year":"2003","journal-title":"Oncogene"},{"issue":"3","key":"10.1016\/j.soc.2014.09.001_bib26","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1016\/j.bbrc.2005.12.089","article-title":"Blocking of G1\/S transition and cell death in the regenerating liver of hepatitis B virus X protein transgenic mice","volume":"340","author":"Wu","year":"2006","journal-title":"Biochem Biophys Res Commun"},{"issue":"3","key":"10.1016\/j.soc.2014.09.001_bib27","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1056\/NEJMoa013215","article-title":"Hepatitis B e antigen and the risk of hepatocellular carcinoma","volume":"347","author":"Yang","year":"2002","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.soc.2014.09.001_bib28","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.jhep.2008.07.023","article-title":"Independent risk factors and predictive score for the development of hepatocellular carcinoma in chronic hepatitis B","volume":"10","author":"Yuen","year":"2009","journal-title":"J\u00a0Hepatol"},{"issue":"1","key":"10.1016\/j.soc.2014.09.001_bib29","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1001\/jama.295.1.65","article-title":"Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level","volume":"295","author":"Chen","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.soc.2014.09.001_bib30","first-page":"962","article-title":"Hepatocellular carcinoma. A worldwide problem and the major risk factors","volume":"36","author":"Simonietti","year":"1991","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.soc.2014.09.001_bib31","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1002\/hep.1840100618","article-title":"Prevalence of hepatocellular carcinoma and relation to cirrhosis: comparison of two different cities in the world\u2013Trieste, Italy and China, Japan","volume":"10","author":"Tiribelli","year":"1989","journal-title":"Hepatology"},{"key":"10.1016\/j.soc.2014.09.001_bib32","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1053\/j.gastro.2003.12.049","article-title":"Increased survival of cirrhotic patients with a hepatocellular carcinoma detected during surveillance","volume":"126","author":"Sangiovanni","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.soc.2014.09.001_bib33","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1136\/gut.2003.020263","article-title":"Natural history of compensated viral cirrhosis: a prospective study on the incidence and hierarchy of major complications","volume":"53","author":"Benvegnu","year":"2004","journal-title":"Gut"},{"key":"10.1016\/j.soc.2014.09.001_bib34","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1038\/bjc.1997.493","article-title":"Effect of hepatitis C and B virus infection on risk of hepatocellular carcinoma: a prospective study","volume":"76","author":"Tsai","year":"1997","journal-title":"Br J Cancer"},{"issue":"2","key":"10.1016\/j.soc.2014.09.001_bib35","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.cld.2011.03.006","article-title":"The global epidemiology of hepatocellular carcinoma: present and future","volume":"15","author":"McGlynn","year":"2011","journal-title":"Clin Liver Dis"},{"issue":"4902","key":"10.1016\/j.soc.2014.09.001_bib36","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1126\/science.2523562","article-title":"Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome","volume":"244","author":"Choo","year":"1989","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.soc.2014.09.001_bib37","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1093\/aje\/155.4.323","article-title":"Alcohol and hepatocellular carcinoma: the effect of lifetime intake and hepatitis virus infections in men and women","volume":"155","author":"Donato","year":"2002","journal-title":"Am J Epidemiol"},{"issue":"Suppl 2","key":"10.1016\/j.soc.2014.09.001_bib38","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1186\/1471-2334-12-S2-S2","article-title":"Chronic HCV infection: epidemiological and clinical relevance","volume":"12","author":"Zaltron","year":"2012","journal-title":"BMC Infect Dis"},{"issue":"4","key":"10.1016\/j.soc.2014.09.001_bib39","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1053\/jhep.2001.27831","article-title":"Estimating progression to cirrhosis in chronic hepatitis C virus infection","volume":"34","author":"Freeman","year":"2001","journal-title":"Hepatology"},{"issue":"5 Suppl 1","key":"10.1016\/j.soc.2014.09.001_bib40","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1002\/hep.1840360706","article-title":"Natural history of chronic hepatitis C","volume":"36","author":"Seeff","year":"2002","journal-title":"Hepatology"},{"issue":"9055","key":"10.1016\/j.soc.2014.09.001_bib41","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/S0140-6736(96)07642-8","article-title":"Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups","volume":"349","author":"Poynard","year":"1997","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.soc.2014.09.001_bib42","first-page":"418","article-title":"The virological and histological states of anti-hepatitis C virus-positive subjects with normal liver biochemical values","volume":"22","author":"Shindo","year":"1995","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.soc.2014.09.001_bib43","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1002\/hep.510270333","article-title":"Slow progression rate of fibrosis in hepatitis C virus patients with persistently normal alanine transaminase activity","volume":"27","author":"Mathurin","year":"1998","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.soc.2014.09.001_bib44","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.cgh.2011.03.004","article-title":"A\u00a0sustained virologic response reduces risk of all-cause mortality in patients with hepatitis C","volume":"9","author":"Backus","year":"2011","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"3","key":"10.1016\/j.soc.2014.09.001_bib45","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.cgh.2009.11.018","article-title":"A\u00a0sustained viral response is associated with reduced liver-related morbidity and mortality in patients with hepatitis C virus","volume":"8","author":"Singal","year":"2010","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"5 Pt 1","key":"10.1016\/j.soc.2014.09.001_bib46","doi-asserted-by":"crossref","first-page":"329","DOI":"10.7326\/0003-4819-158-5-201303050-00005","article-title":"Eradication of hepatitis C virus infection and the development of hepatocellular carcinoma: a meta-analysis of observational studies","volume":"158","author":"Morgan","year":"2013","journal-title":"Ann Intern Med"},{"issue":"3","key":"10.1016\/j.soc.2014.09.001_bib47","first-page":"133","article-title":"Oxidative stress and redox signaling mechanisms of alcoholic liver disease: updated experimental and clinical evidence","volume":"13","author":"Zhu","year":"2012","journal-title":"J\u00a0Dig Dis"},{"key":"10.1016\/j.soc.2014.09.001_bib48","first-page":"1","article-title":"Alcohol drinking","volume":"44","author":"IARC Working Group","year":"1988","journal-title":"IARC Monogr Eval Carcinog Risks Hum"},{"issue":"5","key":"10.1016\/j.soc.2014.09.001_bib49","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1002\/cncr.20427","article-title":"Synergism of alcohol, diabetes, and viral hepatitis on the risk of hepatocellular carcinoma in blacks and whites in the US","volume":"101","author":"Yuan","year":"2004","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.soc.2014.09.001_bib50","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.cld.2012.08.011","article-title":"Liver cancer and alcohol","volume":"16","author":"Grewal","year":"2012","journal-title":"Clin Liver Dis"},{"issue":"2","key":"10.1016\/j.soc.2014.09.001_bib51","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.jhep.2004.10.005","article-title":"Alcohol, tobacco and obesity are synergistic risk factors for hepatocellular carcinoma","volume":"42","author":"Marrero","year":"2005","journal-title":"J\u00a0Hepatol"},{"issue":"22","key":"10.1016\/j.soc.2014.09.001_bib52","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1093\/jnci\/djr395","article-title":"Hepatocellular carcinoma risk factors and disease burden in a European cohort: a nested case-control study","volume":"103","author":"Trichopoulos","year":"2011","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"5","key":"10.1016\/j.soc.2014.09.001_bib53","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.ypmed.2003.11.027","article-title":"A\u00a0meta-analysis of alcohol consumption and the risk of 15 diseases","volume":"38","author":"Corrao","year":"2004","journal-title":"Prev Med"},{"issue":"446","key":"10.1016\/j.soc.2014.09.001_bib54","first-page":"1","article-title":"How the risk of liver cancer changes after alcohol cessation: a review and meta-analysis of the current literature","volume":"11","author":"Heckley","year":"2011","journal-title":"BMC Cancer"},{"issue":"2","key":"10.1016\/j.soc.2014.09.001_bib55","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/0003-9861(83)90482-4","article-title":"Increased chemiluminescence and superoxide production in the liver of chronically ethanol-treated rats","volume":"227","author":"Boveris","year":"1983","journal-title":"Arch Biochem Biophys"},{"issue":"2","key":"10.1016\/j.soc.2014.09.001_bib56","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1006\/abbi.1994.1127","article-title":"Increased production of reactive oxygen species by rat liver mitochondria after chronic ethanol treatment","volume":"309","author":"Kukie\u0142ka","year":"1994","journal-title":"Arch Biochem Biophys"},{"issue":"4","key":"10.1016\/j.soc.2014.09.001_bib57","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1002\/(SICI)1097-0215(20000215)85:4<498::AID-IJC9>3.0.CO;2-F","article-title":"Tobacco smoking, alcohol consumption and their interaction in the causation of hepatocellular carcinoma","volume":"85","author":"Kuper","year":"2000","journal-title":"Int J Cancer"},{"issue":"5","key":"10.1016\/j.soc.2014.09.001_bib58","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1038\/ajg.2010.477","article-title":"Hepatic and extrahepatic cancer in cirrhosis: a longitudinal cohort study","volume":"106","author":"Berman","year":"2011","journal-title":"Am J Gastroenterol"},{"issue":"4","key":"10.1016\/j.soc.2014.09.001_bib59","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S0039-6060(97)90313-5","article-title":"High malignancy of hepatocellular carcinoma in alcoholic patients with hepatitis C virus","volume":"121","author":"Kubo","year":"1997","journal-title":"Surgery"},{"key":"10.1016\/j.soc.2014.09.001_bib60","first-page":"171","article-title":"Aflatoxins","volume":"82","author":"IARC Working Group","year":"2002","journal-title":"IARC Monogr Eval Carcinog Risks Hum"},{"issue":"6","key":"10.1016\/j.soc.2014.09.001_bib61","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1289\/ehp.0901388","article-title":"Global burden of aflatoxin-induced hepatocellular carcinoma: a risk assessment","volume":"118","author":"Liu","year":"2010","journal-title":"Environ Health Perspect"},{"issue":"6317","key":"10.1016\/j.soc.2014.09.001_bib62","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1038\/350427a0","article-title":"Mutational hotspot in the p53 gene in human hepatocellular carcinomas","volume":"350","author":"Hsu","year":"1991","journal-title":"Nature"},{"issue":"6317","key":"10.1016\/j.soc.2014.09.001_bib63","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/350429a0","article-title":"Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa","volume":"350","author":"Bressac","year":"1991","journal-title":"Nature"},{"issue":"8779","key":"10.1016\/j.soc.2014.09.001_bib64","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1016\/0140-6736(91)92236-U","article-title":"p53 mutation in hepatocellular carcinoma after aflatoxin exposure","volume":"338","author":"Ozturk","year":"1991","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.soc.2014.09.001_bib65","first-page":"3","article-title":"A\u00a0follow-up study of urinary markers of aflatoxin exposure and liver cancer risk in Shanghai, People's Republic of China","volume":"3","author":"Qian","year":"1994","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"5","key":"10.1016\/j.soc.2014.09.001_bib66","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1053\/jhep.2003.50193","article-title":"Nonalcoholic steatohepatitis: summary of an AASLD Single Topic Conference","volume":"37","author":"Neuschwander-Tetri","year":"2003","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.soc.2014.09.001_bib67","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.3892\/ijo.2013.2061","article-title":"Non-B, non-C hepatocellular carcinoma (review)","volume":"43","author":"Nishikawa","year":"2013","journal-title":"Int J Oncol"},{"issue":"10","key":"10.1016\/j.soc.2014.09.001_bib68","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1007\/s00535-011-0431-9","article-title":"Hepatocellular carcinoma in Japanese patients with nonalcoholic fatty liver disease, alcoholic liver disease, and chronic liver disease of unknown etiology: report of the nationwide survey","volume":"46","author":"Tokushige","year":"2011","journal-title":"J\u00a0Gastroenterol"},{"issue":"1","key":"10.1016\/j.soc.2014.09.001_bib69","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1055\/s-0032-1306424","article-title":"Nonalcoholic steatohepatitis and noncirrhotic hepatocellular carcinoma: fertile soil","volume":"32","author":"Torres","year":"2012","journal-title":"Semin Liver Dis"},{"issue":"2","key":"10.1016\/j.soc.2014.09.001_bib70","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1002\/hep.24397","article-title":"Metabolic syndrome increases the risk of primary liver cancer in the United States: a study in the SEER-Medicare database","volume":"54","author":"Welzel","year":"2011","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.soc.2014.09.001_bib71","first-page":"13","article-title":"A\u00a0prospective study of obesity and cancer risk (Sweden)","volume":"12","author":"Wolk","year":"2001","journal-title":"Cancer Causes Control"},{"issue":"5","key":"10.1016\/j.soc.2014.09.001_bib72","first-page":"769","article-title":"Cancer among patients with diabetes, obesity and abnormal blood lipids: a population-based register study in Sweden","volume":"23","author":"Attner","year":"2012","journal-title":"Cancer Causes Control"},{"issue":"Suppl 19","key":"10.1016\/j.soc.2014.09.001_bib73","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s00535-008-2262-x","article-title":"Hepatocellular carcinoma in patients with nonalcoholic steatohepatitis","volume":"44","author":"Hashimoto","year":"2009","journal-title":"J\u00a0Gastroenterol"},{"issue":"6","key":"10.1016\/j.soc.2014.09.001_bib74","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1002\/hep.23527","article-title":"The incidence and risk factors of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis","volume":"51","author":"Ascha","year":"2010","journal-title":"Hepatology"},{"issue":"17","key":"10.1016\/j.soc.2014.09.001_bib75","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1056\/NEJMoa021423","article-title":"Overweight, obesity, and mortality from cancer in a prospectively studied cohort of US adults","volume":"348","author":"Calle","year":"2003","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.soc.2014.09.001_bib76","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s00281-012-0336-6","article-title":"Obesity and hepatocellular carcinoma: targeting obesity-related inflammation for chemoprevention of liver carcinogenesis","volume":"35","author":"Shimizu","year":"2013","journal-title":"Semin Immunopathol"},{"issue":"3","key":"10.1016\/j.soc.2014.09.001_bib77","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1038\/ajg.2009.711","article-title":"Neither diabetes mellitus nor overweight is a risk factor for hepatocellular carcinoma in a dual HBV and HCV endemic area: community cross-sectional and case-control studies","volume":"105","author":"Tung","year":"2010","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"10.1016\/j.soc.2014.09.001_bib78","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1053\/j.gastro.2003.10.065","article-title":"Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma","volume":"126","author":"El-Serag","year":"2004","journal-title":"Gastroenterology"},{"issue":"8","key":"10.1016\/j.soc.2014.09.001_bib79","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1002\/cncr.24982","article-title":"Association of diabetes duration and diabetes treatment with the risk of hepatocellular carcinoma","volume":"116","author":"Hassan","year":"2010","journal-title":"Cancer"},{"issue":"12","key":"10.1016\/j.soc.2014.09.001_bib80","doi-asserted-by":"crossref","first-page":"e84776","DOI":"10.1371\/journal.pone.0084776","article-title":"Diabetes mellitus is associated with hepatocellular carcinoma: a retrospective case-control study in hepatitis endemic area","volume":"8","author":"Zheng","year":"2013","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.soc.2014.09.001_bib81","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1093\/annonc\/mdn565","article-title":"The impact of obesity and diabetes mellitus on the risk of hepatocellular carcinoma","volume":"20","author":"Polesel","year":"2009","journal-title":"Ann Oncol"},{"issue":"7","key":"10.1016\/j.soc.2014.09.001_bib82","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1002\/ijc.26165","article-title":"Increased risk of hepatocellular carcinoma in patients with diabetes mellitus: a systematic review and meta-analysis of cohort studies","volume":"130","author":"Wang","year":"2012","journal-title":"Int J Cancer"},{"key":"10.1016\/j.soc.2014.09.001_bib83","first-page":"1","article-title":"Hepatocellular carcinoma","volume":"vol. 1","author":"Hassan","year":"2011"},{"issue":"1","key":"10.1016\/j.soc.2014.09.001_bib84","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1097\/01.mcg.0000190774.91875.d2","article-title":"Liver disease in patients with diabetes mellitus","volume":"40","author":"Harrison","year":"2006","journal-title":"J\u00a0Clin Gastroenterol"},{"issue":"6","key":"10.1016\/j.soc.2014.09.001_bib85","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/j.bcp.2004.05.029","article-title":"An evaluation of the role of insulin-like growth factors (IGF) and of type-I IGF receptor signalling in hepatocarcinogenesis and in the resistance of hepatocarcinoma cells against drug-induced apoptosis","volume":"68","author":"Alexia","year":"2004","journal-title":"Biochem Pharmacol"},{"issue":"11","key":"10.1016\/j.soc.2014.09.001_bib86","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1093\/carcin\/23.11.1781","article-title":"The major lipid peroxidation product, trans-4-hydroxy-2-nonenal, preferentially forms DNA adducts at codon 249 of human p53 gene, a unique mutational hotspot in hepatocellular carcinoma","volume":"23","author":"Hu","year":"2002","journal-title":"Carcinogenesis"},{"issue":"5","key":"10.1016\/j.soc.2014.09.001_bib87","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1111\/j.1478-3231.2010.02223.x","article-title":"Metformin and reduced risk of hepatocellular carcinoma in diabetic patients with chronic liver disease","volume":"30","author":"Donadon","year":"2010","journal-title":"Liver Int"},{"issue":"6","key":"10.1016\/j.soc.2014.09.001_bib88","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1053\/j.gastro.2003.09.035","article-title":"Cancer risk in patients with hereditary hemochromatosis and in their first-degree relatives","volume":"125","author":"Elmberg","year":"2003","journal-title":"Gastroenterology"},{"issue":"11","key":"10.1016\/j.soc.2014.09.001_bib89","doi-asserted-by":"crossref","first-page":"946","DOI":"10.7326\/0003-4819-129-11_Part_2-199812011-00005","article-title":"Hemochromatosis-associated mortality in the United States from 1979 to 1992: an analysis of multiple-cause mortality data","volume":"129","author":"Yang","year":"1998","journal-title":"Ann Intern Med"},{"issue":"4\u20135","key":"10.1016\/j.soc.2014.09.001_bib90","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1159\/000320057","article-title":"Chronic liver diseases as liver tumor precursors","volume":"28","author":"Lata","year":"2010","journal-title":"Dig Dis"},{"issue":"2","key":"10.1016\/j.soc.2014.09.001_bib91","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1093\/ije\/29.2.232","article-title":"Prospective study on the relation of cigarette smoking with cancer of the liver and stomach in an endemic region","volume":"29","author":"Mizoue","year":"2000","journal-title":"Int J Epidemiol"},{"issue":"1","key":"10.1016\/j.soc.2014.09.001_bib92","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.cdp.2004.08.006","article-title":"Cigarette smoking and cancer incidence risk in adult men: National Health Insurance Corporation Study","volume":"29","author":"Yun","year":"2005","journal-title":"Cancer Detect Prev"},{"issue":"3","key":"10.1016\/j.soc.2014.09.001_bib93","first-page":"315","article-title":"Cigarette smoking and primary liver cancer: a population-based case-control study in US men","volume":"18","author":"Zhu","year":"2007","journal-title":"Cancer Causes Control"},{"issue":"24","key":"10.1016\/j.soc.2014.09.001_bib94","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1093\/jnci\/djh334","article-title":"Cigarette smoking, alcohol drinking, hepatitis B, and risk for hepatocellular carcinoma in Korea","volume":"96","author":"Jee","year":"2004","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"8","key":"10.1016\/j.soc.2014.09.001_bib95","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1093\/aje\/kwg041","article-title":"Incidence and cofactors of hepatitis C virus-related hepatocellular carcinoma: a prospective study of 12,008 men in Taiwan","volume":"157","author":"Sun","year":"2003","journal-title":"Am J Epidemiol"},{"issue":"8442","key":"10.1016\/j.soc.2014.09.001_bib96","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1016\/S0140-6736(85)91785-4","article-title":"Risk factors in development of hepatocellular carcinoma in cirrhosis: prospective study of 613 patients","volume":"1","author":"Zaman","year":"1985","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.soc.2014.09.001_bib97","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1002\/ijc.2910630405","article-title":"A\u00a0cohort study of serum testosterone and hepatocellular carcinoma in Shanghai, China","volume":"63","author":"Yuan","year":"1995","journal-title":"Int J Cancer"},{"issue":"5834","key":"10.1016\/j.soc.2014.09.001_bib98","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1126\/science.1140485","article-title":"Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production","volume":"317","author":"Naugler","year":"2007","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.soc.2014.09.001_bib99","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1053\/jlts.2003.50073","article-title":"Projecting future complications of chronic hepatitis C in the United States","volume":"9","author":"Davis","year":"2003","journal-title":"Liver Transpl"},{"issue":"5","key":"10.1016\/j.soc.2014.09.001_bib100","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1053\/gast.2002.32978","article-title":"The burden of selected digestive diseases in the United States","volume":"122","author":"Sandler","year":"2002","journal-title":"Gastroenterology"}],"container-title":["Surgical Oncology Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1055320714000799?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1055320714000799?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T11:59:38Z","timestamp":1760961578000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1055320714000799"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1]]},"references-count":100,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,1]]}},"alternative-id":["S1055320714000799"],"URL":"https:\/\/doi.org\/10.1016\/j.soc.2014.09.001","relation":{},"ISSN":["1055-3207"],"issn-type":[{"value":"1055-3207","type":"print"}],"subject":[],"published":{"date-parts":[[2015,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Epidemiology of Hepatocellular Carcinoma","name":"articletitle","label":"Article Title"},{"value":"Surgical Oncology Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.soc.2014.09.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}